EUVIMEDEUVIMED entdecken
Open Access

Stimuli-responsive nanomaterials for targeted drug delivery in inflammatory bowel disease: Advances and emerging directions

Wenpeng Huang, Jessica C Hsu, Jingwei Zhou, Glen S Kwon, Lei Kang, Chen Hua, Weibo Cai

Matter · 2025-09 · 8 (9) · 102249

DOI: 10.1016/j.matt.2025.102249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Matter, 2025-09. Verfasst von Wenpeng Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Peking University First Hospital, National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a chronic and increasingly prevalent gastrointestinal disorder that remains difficult to treat due to the limited efficacy of conventional therapies, often compromised by premature drug release and systemic side effects. Stimuli-responsive nanomaterials have emerged as a promising solution, enabling targeted and controlled drug delivery at inflamed sites to enhance therapeutic outcomes and reduce toxicity. This review systematically examines the recent development and application of these smart nanomaterial drug-delivery systems for IBD therapy over the past years. By responding to the unique pathological features of the IBD microenvironment, these systems enable improved drug targeting and site-specific release. Despite significant progress, challenges such as scalable manufacturing, long-term safety, and clinical translation remain. Future research may focus on reducing batch-to-batch variation, conducting comprehensive safety assessments, and integrating personalized medicine approaches to fully harness the potential of stimuli-responsive nanomaterials in IBD treatment.

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
  • Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, WI 53705, USA.
  • These authors contributed equally.
  • Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
  • School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.

Förderung

  • NCI NIH HHS
  • Peking University First Hospital
  • National Institutes of Health
  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
  • University of Wisconsin-Madison
  • National Natural Science Foundation of China

Zitieren

APA

Huang, W., Hsu, J. C., Zhou, J., Kwon, G. S., Kang, L., Hua, C., & Cai, W. (2025). Stimuli-responsive nanomaterials for targeted drug delivery in inflammatory bowel disease: Advances and emerging directions. Matter, 8(9), 102249. https://doi.org/10.1016/j.matt.2025.102249

Vancouver

Huang W, Hsu JC, Zhou J, Kwon GS, Kang L, Hua C, et al. Stimuli-responsive nanomaterials for targeted drug delivery in inflammatory bowel disease: Advances and emerging directions. Matter. 2025;8(9):102249. doi:10.1016/j.matt.2025.102249

BibTeX
@article{Huang2025,
  author = {Huang, Wenpeng and Hsu, Jessica C and Zhou, Jingwei and Kwon, Glen S and Kang, Lei and Hua, Chen and Cai, Weibo},
  title = {Stimuli-responsive nanomaterials for targeted drug delivery in inflammatory bowel disease: Advances and emerging directions},
  journal = {Matter},
  year = {2025},
  volume = {8},
  number = {9},
  pages = {102249},
  doi = {10.1016/j.matt.2025.102249}
}
Kostenlos starten →